XOMA Co. (NASDAQ:XOMAO) Announces Quarterly Dividend of $0.52

XOMA Co. (NASDAQ:XOMAOGet Rating) announced a quarterly dividend on Thursday, September 22nd, Wall Street Journal reports. Stockholders of record on Monday, October 3rd will be paid a dividend of 0.5234 per share on Monday, October 17th. This represents a $2.09 annualized dividend and a dividend yield of 8.44%. The ex-dividend date is Friday, September 30th.

XOMA Stock Down 0.3 %

XOMA stock opened at $24.82 on Friday. The firm has a fifty day simple moving average of $25.25. XOMA has a 52 week low of $24.34 and a 52 week high of $27.00.

Insider Activity at XOMA

In related news, CFO Thomas M. Burns sold 2,000 shares of the company’s stock in a transaction on Friday, July 15th. The stock was sold at an average price of $31.66, for a total value of $63,320.00. Following the completion of the transaction, the chief financial officer now directly owns 6,555 shares in the company, valued at $207,531.30. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other XOMA news, CFO Thomas M. Burns sold 2,000 shares of the company’s stock in a transaction dated Friday, July 15th. The stock was sold at an average price of $31.66, for a total transaction of $63,320.00. Following the completion of the sale, the chief financial officer now directly owns 6,555 shares in the company, valued at $207,531.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Bvf Partners L. P/Il purchased 26,441 shares of the company’s stock in a transaction on Wednesday, September 14th. The shares were purchased at an average price of $17.25 per share, with a total value of $456,107.25. Following the completion of the purchase, the director now directly owns 1,571,338 shares of the company’s stock, valued at $27,105,580.50. The disclosure for this purchase can be found here.

About XOMA

(Get Rating)

XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies.

Further Reading

Receive News & Ratings for XOMA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOMA and related companies with MarketBeat.com's FREE daily email newsletter.